Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Approval of Audited Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Skybiotech Healthcare Ltd has informed BSE that its Board of Directors meeting is scheduled for May 30, 2026. The meeting will consider and approve the audited financial results and limited review report for the quarter and financial year ended March 31, 2026. This is a routine pre-results announcement notice filed under SEBI LODR Regulations. The actual financial numbers and any auditor opinions will be disclosed after the meeting concludes.
This is a standard procedural filing. The actual results to be approved on May 30, 2026 will determine the company's financial performance and any associated signals for investors.